Novo Nordisk announced the launch of NovoFine Plus, their thinnest and shortest pen needles currently available. These needles are compatible with all available insulin and some GLP-1 receptor agonist ...

NovoFine Plus uses SuperFlow technology, which offers patients faster injections that require less force. It has been designed to reduce the risk of bending or breakage and is compatible with all ...

LONDON (Reuters) - Britain's medicines watchdog said on Friday it had discovered a batch of counterfeit Novo Nordisk insulin pen needles circulating in the country and urged diabetics not to use them.

For example, a real Ozempic needle should be covered by a paper tab that reads “NovoFine Plus,” while the counterfeit needles found so far simply say “NovoFine.” Consumers can also compare the lot and ...

PRINCETON, N.J. Novo Nordisk is extending the availability of its safety insulin needle, NovoFine Autocover 30G from hospitals to retail pharmacies. The needle has a plastic shield that helps reduce ...

Novo Nordisk will shell out $6.3 million to settle allegations from the Department of Justice (DOJ) that the company violated U.S. law by selling injection needles to the government that it ...

The US Food and Drug Administration (FDA) has issued a warning to the public about counterfeit semaglutide (Ozempic) products that have entered the US drug supply. Clinicians and patients are advised ...

Novo Nordisk ( NVO) launched its shortest and ultra thin needle, NovoFine Plus, in Canada. The needle aims to make injections more comfortable for diabetic patients. It is also scheduled for launch in ...